Applied Therapeutics (APLT) Competitors $0.52 +0.03 (+5.56%) Closing price 04:00 PM EasternExtended Trading$0.53 +0.01 (+2.48%) As of 04:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock APLT vs. FHTX, DSGN, NGNE, AVIR, GLUE, DBVT, CTNM, VOR, LFCR, and ACBShould you be buying Applied Therapeutics stock or one of its competitors? The main competitors of Applied Therapeutics include Foghorn Therapeutics (FHTX), Design Therapeutics (DSGN), Neurogene (NGNE), Atea Pharmaceuticals (AVIR), Monte Rosa Therapeutics (GLUE), DBV Technologies (DBVT), Contineum Therapeutics (CTNM), Vor Biopharma (VOR), Lifecore Biomedical (LFCR), and Aurora Cannabis (ACB). These companies are all part of the "pharmaceutical products" industry. Applied Therapeutics vs. Its Competitors Foghorn Therapeutics Design Therapeutics Neurogene Atea Pharmaceuticals Monte Rosa Therapeutics DBV Technologies Contineum Therapeutics Vor Biopharma Lifecore Biomedical Aurora Cannabis Foghorn Therapeutics (NASDAQ:FHTX) and Applied Therapeutics (NASDAQ:APLT) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, media sentiment, institutional ownership, profitability, valuation and earnings. Which has more volatility and risk, FHTX or APLT? Foghorn Therapeutics has a beta of 3.05, meaning that its stock price is 205% more volatile than the S&P 500. Comparatively, Applied Therapeutics has a beta of 2.05, meaning that its stock price is 105% more volatile than the S&P 500. Which has preferable earnings and valuation, FHTX or APLT? Foghorn Therapeutics has higher revenue and earnings than Applied Therapeutics. Foghorn Therapeutics is trading at a lower price-to-earnings ratio than Applied Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFoghorn Therapeutics$22.60M13.21-$86.62M-$1.19-4.44Applied Therapeutics$460K162.83-$105.62M-$0.45-1.16 Does the media prefer FHTX or APLT? In the previous week, Foghorn Therapeutics had 1 more articles in the media than Applied Therapeutics. MarketBeat recorded 4 mentions for Foghorn Therapeutics and 3 mentions for Applied Therapeutics. Applied Therapeutics' average media sentiment score of 1.33 beat Foghorn Therapeutics' score of 1.09 indicating that Applied Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Foghorn Therapeutics 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Applied Therapeutics 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer FHTX or APLT? Foghorn Therapeutics currently has a consensus target price of $10.67, suggesting a potential upside of 102.02%. Applied Therapeutics has a consensus target price of $6.10, suggesting a potential upside of 1,072.85%. Given Applied Therapeutics' higher possible upside, analysts plainly believe Applied Therapeutics is more favorable than Foghorn Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Foghorn Therapeutics 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 3.17Applied Therapeutics 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Is FHTX or APLT more profitable? Applied Therapeutics has a net margin of 0.00% compared to Foghorn Therapeutics' net margin of -311.90%. Foghorn Therapeutics' return on equity of 0.00% beat Applied Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Foghorn Therapeutics-311.90% N/A -28.00% Applied Therapeutics N/A -354.24%-144.16% Do insiders and institutionals hold more shares of FHTX or APLT? 61.6% of Foghorn Therapeutics shares are held by institutional investors. Comparatively, 98.3% of Applied Therapeutics shares are held by institutional investors. 7.6% of Foghorn Therapeutics shares are held by company insiders. Comparatively, 1.6% of Applied Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. SummaryFoghorn Therapeutics beats Applied Therapeutics on 9 of the 16 factors compared between the two stocks. Get Applied Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APLT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding APLT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APLT vs. The Competition Export to ExcelMetricApplied TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$74.90M$3.10B$5.69B$9.68BDividend YieldN/A2.28%6.66%4.54%P/E Ratio-1.1620.9982.6526.40Price / Sales162.83396.26529.10204.59Price / CashN/A43.5325.7028.92Price / Book1.069.8811.246.06Net Income-$105.62M-$53.38M$3.28B$266.05M7 Day Performance-2.51%-0.14%0.15%-0.07%1 Month Performance18.02%9.18%8.36%5.83%1 Year Performance-91.80%7.53%54.25%17.89% Applied Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APLTApplied Therapeutics4.0915 of 5 stars$0.52+5.6%$6.10+1,072.9%-92.2%$74.90M$460K-1.1630Positive NewsGap UpFHTXFoghorn Therapeutics2.6695 of 5 stars$5.03-4.4%$10.67+112.0%-38.9%$284.57M$22.60M-4.23120News CoveragePositive NewsDSGNDesign Therapeutics0.1503 of 5 stars$4.94+3.1%N/A+16.4%$281.33MN/A-4.4140News CoverageNGNENeurogene2.0963 of 5 stars$19.65+0.2%$46.17+134.9%-50.6%$278.98M$930K-4.5490News CoveragePositive NewsAVIRAtea Pharmaceuticals2.5467 of 5 stars$3.52+0.4%$6.00+70.7%-12.7%$278.95MN/A-2.1870News CoverageGLUEMonte Rosa Therapeutics2.7396 of 5 stars$4.47+0.8%$15.33+243.4%-22.2%$275.76M$75.62M12.4090News CoveragePositive NewsDBVTDBV Technologies3.309 of 5 stars$10.02+2.2%$14.75+47.3%+112.9%$274.31M$4.15M-2.1080Positive NewsCTNMContineum Therapeutics2.5726 of 5 stars$9.74+9.8%$22.75+133.6%-46.4%$273.11M$50M-4.4331Short Interest ↑VORVor Biopharma1.8145 of 5 stars$2.15-2.5%$6.07+182.8%+125.3%$273.00MN/A-1.31140LFCRLifecore Biomedical0.684 of 5 stars$7.28+0.5%$8.00+10.0%+73.7%$272.16M$128.87M-5.55690News CoveragePositive NewsACBAurora Cannabis0.2114 of 5 stars$4.80+1.6%N/A-10.9%$270.23M$246.72M-25.191,130Gap Down Related Companies and Tools Related Companies Foghorn Therapeutics Alternatives Design Therapeutics Alternatives Neurogene Alternatives Atea Pharmaceuticals Alternatives Monte Rosa Therapeutics Alternatives DBV Technologies Alternatives Contineum Therapeutics Alternatives Vor Biopharma Alternatives Lifecore Biomedical Alternatives Aurora Cannabis Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:APLT) was last updated on 9/2/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredLeaked Gov’t Memo Reveals $100 Trillion DeadlineOnly Days Left to Claim Your Share of Trump's $100T Play Trump's economic blueprint is about to go live, an...Stansberry Research | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Applied Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Applied Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free APLT Stock Alerts